Dive into the challenges facing clinical trial recruitment and enrollment today, where a staggering 80% of studies struggle to meet enrollment timelines. Improving patient recruitment requires innovative solutions, especially for genetically targeted therapies – both those in development as well as those already commercially available.

We will discuss and address these questions:

1. How can you quickly pinpoint participants who match your therapy and/or study’s unique inclusion/exclusion criteria?
2. How can you further streamline and expedite that patient qualification process?
3. And, most critically, how can you reach these individuals directly and engage them to enroll in your clinical trial?

Many traditional recruitment methods rely on broad consumer or provider outreach that entails numerous qualification stages and doesn’t initially take potential patient interest into account. But what if there was a way to bypass the bulk of these hurdles to access highly qualified and motivated patients?

Learn how a nationwide patient identification and activation service enables biopharma and patient recruitment organizations to quickly identify the right patients for their therapies, at the right time in their health journey and activate these patients for trial enrollment.